Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0G8NP
|
||||
| Former ID |
DIB015473
|
||||
| Drug Name |
CS-00028
|
||||
| Synonyms |
CS-028; HDAC antagonist (cancer), Shenzhen Chipscreen Biosciences
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Preclinical | [1] | ||
| Company |
Shenzhen Chipscreen Biosciences Ltd
|
||||
| Target and Pathway | |||||
| Target(s) | Histone deacetylase | Target Info | Antagonist | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021167) | ||||
| REF 2 | US patent application no. 2009,0162,329, Compositions comprising hdac inhibitors and methods of their use in restoring stem cell function and preventing heart failure. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.